Monoamine oxidase in developing rat renal cortex: effect of dexamethasone treatment.
The expression of the biogenic amine degrading enzyme monoamine oxidases-A and -B depends on several factors including regional distribution, development and hormonal environment. In the present study, we investigated the expression of monoamine oxidases in developing kidney and their regulation by dexamethasone treatment. Immunoblots and enzyme assays, performed using [14C]5-hydroxytriptamine and [14C]beta-phenylethylamine as substrates for monoamine oxidases-A and -B, respectively, showed that monoamine oxidase-A is the isoenzyme largely predominant in 9-day-old rats renal cortex. Experiments performed in 5-week-old rats showed an increase in monoamine oxidase-B activity and a decrease in monoamine oxidase-A activity and substrate affinity. The changes of monoamine oxidase-A activity and affinity were mimicked by dexamethasone treatment (0.60 mg/kg body weight injected subcutaneously three times at intervals of 24 h) of 9-day-old rats. In contrast, dexamethasone administration induced a modification of monoamine oxidase-B activity opposite to that found between 9-day- and 5-week-old rats. Dexamethasone treatment did not modify immunoreactivity and mRNA corresponding to monoamine oxidases-A and -B indicating that changes of enzyme activities were unrelated to regulation of protein synthesis and mRNA turnover. These results show that monoamine oxidases-A and -B are differently expressed in developing renal cortex and are regulated by dexamethasone treatment.
Bompart
G
G
INSERM U388, CHU Rangueil, 31403 Toulouse Cedex 4, France.
Copin
N
N
Djouadi
F
F
Bastin
J
J
Ordener
C
C
Parini
A
A
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D005260:Female; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D015151:Immunoblotting; D007672:Kidney Cortex / Q000187:drug effects / Q000201:enzymology* / Q000254:growth & development; D008297:Male; D008995:Monoamine Oxidase / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D010627:Phenethylamines / Q000378:metabolism; D011247:Pregnancy; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012701:Serotonin / Q000378:metabolism; D013379:Substrate Specificity
D000893:Anti-Inflammatory Agents; D010627:Phenethylamines; D012333:RNA, Messenger; C029261:phenethylamine; D012701:Serotonin; D003907:Dexamethasone; D008995:Monoamine Oxidase